ID: ALA3715818
Chembl Id: CHEMBL3715818
PubChem CID: 58345752
Max Phase: Preclinical
Molecular Formula: C14H19N3O
Molecular Weight: 245.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1nc2ccc(O)nc2n1C1(C)CCCCC1
Standard InChI: InChI=1S/C14H19N3O/c1-10-15-11-6-7-12(18)16-13(11)17(10)14(2)8-4-3-5-9-14/h6-7H,3-5,8-9H2,1-2H3,(H,16,18)
Standard InChI Key: AERLRAKXYYVVCJ-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 245.33 | Molecular Weight (Monoisotopic): 245.1528 | AlogP: 3.12 | #Rotatable Bonds: 1 |
| Polar Surface Area: 50.94 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 11.85 | CX Basic pKa: 3.07 | CX LogP: 3.13 | CX LogD: 3.13 |
| Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.84 | Np Likeness Score: -0.59 |
| 1. (2013) 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders, |
Source(1):
